Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000500477 | SCV000595625 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000057231 | SCV000701838 | uncertain significance | not provided | 2016-10-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001178173 | SCV001342549 | likely benign | Cardiomyopathy | 2018-12-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000057231 | SCV001473506 | likely benign | not provided | 2020-04-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001437348 | SCV001640201 | likely benign | Charcot-Marie-Tooth disease type 2 | 2023-11-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000057231 | SCV001746872 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453371 | SCV002737584 | likely benign | Cardiovascular phenotype | 2021-07-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003996496 | SCV004818455 | likely benign | Primary dilated cardiomyopathy | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Epithelial Biology; Institute of Medical Biology, |
RCV000057231 | SCV000088344 | not provided | not provided | no assertion provided | not provided |